Table: begin end state 1 30 cytoplasmic 31 54 transmembrane 55 60 non-cytoplasmic 61 83 transmembrane 84 94 cytoplasmic 95 115 transmembrane 116 164 non-cytoplasmic 165 184 transmembrane 185 191 cytoplasmic 192 213 transmembrane 214 232 non-cytoplasmic 233 251 transmembrane 252 271 cytoplasmic 272 296 transmembrane 297 316 non-cytoplasmic 317 340 transmembrane 341 369 cytoplasmic 370 388 transmembrane 389 393 non-cytoplasmic 394 416 transmembrane 417 426 cytoplasmic 427 446 transmembrane 447 451 non-cytoplasmic 452 470 transmembrane 471 480 cytoplasmic
Input: >N515DRAFT_2925 FitnessBrowser__Dyella79:N515DRAFT_2925 MLKQLFARKTDFSDADDCHGGPSLRRTLGKWGITALGIGAVIGTGIFVVTGQAAAEHAGP AVLISFMLAAICSGFTALCYAEFATLIPISGSSYSYAYATLGELVAWFIGWNMVLEYGIS ASAVAASWTGYFTSLLDHVGIHLPVALTEAPLAFKDGHLVTTGHLLNLPAVAIVLALTWL CYVGIRESSGLNVLMVALKVGLIIVVVVAGYRYVDPANWHPFIPAEQEPGKYGWSGIMRG AAMVFFAYIGFEATSTAAQECKNPQKDLPFGTLVSLVICTVLYLAMAAVLTGLIPYTELG TSEPVVTAIRNHPELGWLRLVVEIGAMIGLSSVILVMIIAQPRIFMIMSRDGLLPPVFNR IHPKHRTPHLNTVITGIGIAILAAVFPLDLLADLTSMGTLIAFVAVCAGVLILRYTAPEL PRLFRVPAAWFVCTAGVFSCLALLYFMAWFNWLLMIIWTAIGLAIYFGYGMRHSRLRRAS
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server